Table of Contents
<< Previous Issue | May 2003 (Vol: 2003, Issue: 36) | Next Issue >> |
- Section: Company Profile
-
Leo Pharma A/S
- Section: Distribution & Marketing
-
Novo Nordisk and Fournier Pharma Sign Co-Marketing Agreement for Repaglinide in Europe
-
Eyetech Pharmaceuticals Enters Deal to Market Pfizer’s Xalatan®
- Section: General
-
Shire and Noven in ADHD Deal
-
Celltech, Oxford GlycoSciences and the Bidding War That Never Was
-
Therapy Focus: Psoriasis
- Section: Licensing
-
Guilford Licenses Neurological Drugs to Pfizer
-
GSK and Neose in Vaccine Deal
- Section: Mergers & Acquisitions
-
Quintiles moves from Public to Private via cash Merger
- Section: Research & Development
-
Schering and Astex Enter Multi-target Drug Discovery Alliance
-
Allergen and Acadia Enter Third Drug Discovery Collaboration